3
Announcements
Trials
Browse
Landscape
Phase
Phase 1
1
Status
Active not recruiting
3
Terminated
1
Recruiting
1
Not yet recruiting
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Gastrointestinal
1
Conditions
Breast Neoplasms
17
Carcinoma, Non-Small-Cell Lung
14
Ovarian Neoplasms
7
Fallopian Tube Neoplasms
7
Pancreatic Neoplasms
6
Triple Negative Breast Neoplasms
5
Lung Neoplasms
4
Neoplasms
3
Neoplasm Metastasis
3
Inflammatory Breast Neoplasms
3
Adenocarcinoma of Lung
3
Stomach Neoplasms
2
Squamous Cell Carcinoma of Head and Neck
2
Multiple Myeloma
2
Melanoma
2
Endometrial Neoplasms
2
Carcinoma, Ovarian Epithelial
2
Breast Neoplasms, Male
2
Adenocarcinoma, Bronchiolo-Alveolar
2
Adenocarcinoma Of Esophagus
2
Adenocarcinoma
2
Turcot syndrome
1
Thrombocytosis
1
Stages II-III Breast Cancer
1
Stage IIIA Lung Non-Small Cell Cancer AJCC v7
1
Stage IA Uterine Sarcoma
1
Salivary Gland Neoplasms
1
Recurrence
1
Prostatic Neoplasms
1
Primary Myelofibrosis
1
Interventions
Carboplatin
7
Pemetrexed
5
pembrolizumab
4
Gemcitabine
4
osimertinib
3
Sorafenib
3
Paclitaxel
3
Interleukin-2
3
Cyclophosphamide
3
Cisplatin
3
seocalcitol
2
selinexor
2
patritumab
2
liposomal doxorubicin
2
interferon gamma-1b
2
fludarabine
2
Sunitinib
2
Radiotherapy, Intensity-Modulated
2
Radiotherapy
2
Irinotecan
2
Erlotinib Hydrochloride
2
DNA
2
Celecoxib
2
Capecitabine
2
Bleomycin
2
Bevacizumab
2
Albumin-Bound Paclitaxel
2
130-nm albumin-bound paclitaxel
2
volociximab
1
thioredoxin reductase inhibitor AM12
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Terminated
×
Carcinoma
×
Taxes
×
Clear all
NCT05494866
2025-03-25
IntenSify
German Cancer Research Center
Phase 1
Terminated
6 enrolled